Home Drugs SGLT2 inhibitors (drug class)
Registry trials: SGLT2 inhibitors (drug class) 14 registry trials linked to SGLT2 inhibitors (drug class) with registry status unknown status, of 94, newest start first. Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Each filter is a page of its own, so they work one at a time. Choose Whole list to start again.
Phase 4 Unknown status Planned start 2024-05-01 154 planned NCT06350487
Phase 3 Unknown status Started 2023-11-07 492 planned NCT06124937
Phase 4 Unknown status Started 2023-09-01 348 planned NCT05816733
Phase 4 Unknown status Planned start 2022-12-15 100 planned NCT05584319
Phase 4 Unknown status Planned start 2022-11-15 120 planned NCT05550441
Phase 4 Unknown status Started 2022-11-05 100 planned NCT05600387
Phase 3 Unknown status Started 2022-09-16 100 planned NCT05020704
Phase 3 Unknown status Started 2022-04-15 120 planned NCT05957887
Phase 2/3 Unknown status Started 2022-02-12 106 planned NCT05241431
Phase 4 Unknown status Started 2022-01-01 600 planned NCT05225077
Phase 4 Unknown status Planned start 2021-09 400 planned NCT04583813
Phase 4 Unknown status Started 2021-08-06 1,990 planned NCT04707261
Phase 4 Unknown status Started 2021-01-01 500 planned NCT04340908
Phase 3 Unknown status Planned start 2019-03-01 576 planned NCT03658031